Itraconazole, Sporanox | 22484 | TABLET;ORAL | 200MG

Itraconazole (Sporanox)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

91 API Suppliers, 14 USDMF, 16 CEP/COS, 5 JDMF, 14 EU WC, 19 KDMF, 16 NDC API, 51 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

160 Drugs in Development

160 Drugs in Development

INTERMEDIATES

30 Intermediate Suppliers

30 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

197 FDF Dossiers, 20 FDA Orange Book, 60 Europe, 5 Canada, 3 Australia, 13 South Africa, 96 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, TABLET;ORAL - 200MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 6 SPI Pharma, 11 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 24 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 29 Thickeners and Stabilizers, 23 Controlled & Modified Release, 19 Taste Masking, 19 Direct Compression, 18 Granulation, 17 Solubilizers, 17 Film Formers & Plasticizers, 14 Lubricants & Glidants, 13 Topical, 12 Parenteral, 11 Co-Processed Excipients, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

37 News #PharmaBuzz

37 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 23 Regulatory FDF Prices

MARKET PLACE

45 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22484 / DOSAGE - TABLET;ORAL - 200MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ITRACONAZOLE(UNII: 304NUG5GF4) (ITRACONAZOLE - UNII:304NUG5GF4)	ITRACONAZOLE	200mg

Inactive Ingredients

Ingredient Name	Merz Pharmaceuticals, LLC
CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
PROPYLENE GLYCOL(6DC9Q167V3)
SILICON DIOXIDE(ETJ7Z6XBU4)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Itraconazole, Sporanox